Related Experiment Video
Updated: Jul 7, 2026

13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
19.7K
G4-SLSELEX-Seq-driven discovery of a G4-specific targeting L-RNA aptamer with unique structural features.
Tian-Ying Wu1, Chun Kit Kwok1,2
1Department of Chemistry and State Key Laboratory of Marine Pollution, City University of Hong Kong, Kowloon Tong, Hong Kong SAR 999077, China. ckkwok42@cityu.edu.hk.
Organic & Biomolecular Chemistry
|July 10, 2025
Summary
Researchers developed a new method for aptamer selection against DNA G-quadruplexes (dG4s). This led to the discovery of L-Apt.G3, an L-RNA aptamer with high affinity and dual-specificity for dG4s, capable of disrupting dG4-protein interactions.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- DNA G-quadruplexes (dG4s) are unique nucleic acid structures with significant biological roles.
- Aptamers are valuable tools for studying and targeting nucleic acid structures.
- Developing specific aptamers for dG4s remains a challenge.
Purpose of the Study:
- To develop a novel aptamer selection strategy for DNA G-quadruplexes (dG4s).
- To identify and characterize L-RNA aptamers with high affinity and specificity for dG4s.
- To investigate the potential of aptamers in disrupting dG4-protein interactions.
Main Methods:
- Integration of sequence-guided library design with G4-SELEX-Seq.
- Selection and characterization of L-RNA aptamers against various dG4 structures.
- Affinity measurements using techniques like Surface Plasmon Resonance (SPR).
- Assessment of aptamer's ability to disrupt dG4-protein binding.
Main Results:
- The integrated approach successfully yielded aptamers targeting dG4s.
- Identified L-Apt.G3, the first L-RNA aptamer with low nanomolar binding affinity for dG4s.
- L-Apt.G3 demonstrated dual-specificity for both parallel and antiparallel dG4 conformations.
- L-Apt.G3 effectively competed with proteins binding to dG4s.
Conclusions:
- Sequence-guided library design enhances aptamer selection for complex targets like dG4s.
- L-Apt.G3 represents a novel and potent dG4-targeting aptamer with therapeutic and diagnostic potential.
- This study provides a powerful platform for developing aptamers against G-quadruplex structures.

